Yuan, J., Jiang, Y., Chen, F., Li, T., Zeng, Z., Ruan, S., . . . Tong, Q. (2025). Clinical implications of DNA ploidy, stroma, and nucleotyping in predicting peritoneal metastasis risk for gastric cancer. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-13564-8
Chicago Style (17th ed.) CitationYuan, Jingwen, et al. "Clinical Implications of DNA Ploidy, Stroma, and Nucleotyping in Predicting Peritoneal Metastasis Risk for Gastric Cancer." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-13564-8.
MLA (9th ed.) CitationYuan, Jingwen, et al. "Clinical Implications of DNA Ploidy, Stroma, and Nucleotyping in Predicting Peritoneal Metastasis Risk for Gastric Cancer." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-13564-8.